MSB 7.69% $1.19 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-367

  1. 4,638 Posts.
    lightbulb Created with Sketch. 166
    I am a big believer in MSB and stem cell therapy ... but I also don't trust the FDA to do the right thing ... remember how long a what a fight for VCR ... they lost!
    how about AVH ... stymied for 15 years or more ... and now MSB with a sensational product for COVID 19 and still not approved for emergencies except in a trial ... which , In my opinion, may get orphan status and not full approval ... too much potential losses for big pharma ... just my humble opinion .. maybe down the road approval ... maybe a takeover to control its usage ... I don't know but certainly do t trust FDA and certainly not with Trump in power
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.